Comparison of the hyperlipidemic models and lipid-lowering pharmacodynamics between Dunkin Hartley albino guinea pigs and Hartley pigment guinea pigs
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference [12]
  • | | | |
  • Comments
    Abstract:

    Objective To compare the differences of two stocks of guinea pigs, the albino guinea pigs and pigment guinea pigs, in establishing dyslipidemic model, to evaluate their lipid-lowering action, and to compare their properties for development of hyperlipidemia. Methods Two stocks of the 5-week-old guinea pigs were randomly divided into two groups, normal group (NC) and model group (Model). For the NC group, 12 guinea pigs were fed with normal chew. For the model group, after fed with high-fat diet for four weeks, 24 male guinea pigs were randomly grouped and treated with vehicle (VC group) and pitavastatin (Pit group) calcium, respectively, by gavage as well as received high-fat diet. Before and after modeling and pitavastatin treatment, blood samples were collected and subjected to analysis of plasma TC, TG, HDL-C and LDL-C, respectively. Results In the normal group, the blood lipid levels of albino guinea pigs were more stable than that of the pigmented pigs with the increase of age. After fed with high-fat diet, the plasma lipid levels of TC, TG and LDL-C were significantly increased in the two strains of guinea pigs, while HDL-C showed a decrease to varying degrees. Interestingly, the lipid level in the albino guinea pigs was significantly higher than that of pigment guinea pigs. And also, after drug administration for four weeks, pitavastatin treatment significantly decreased the elevated lipid level of TC, TG and LDL-C in the albino guinea pigs compared with that in the pigment guinea pigs. Conclusions The albino guinea pigs and pigment guinea pigs demonstrate certain differences in establishing dyslipidemic model and evaluating lipid-lowering pharmacodynamics. However, compared with the pigment guinea pigs, the albino guinea pigs have obvious superiority because of easy establishment of hyperlipidemia model and are more sensitive to lipid-lowering drugs.

    Reference
    [1] Bahmani M, Mirhoseini M, Shirzad H, et al. A review on promising natural agents effective on hyperlipidemia [J]. J Evidence-Based Compl Altern Med, 2015, 12: 1-11.
    [2] 李大伟, 张玲, 夏作理. 建立高脂血症模型的动物选择与常用造模方法分析与改进 [J].中国临床康复, 2006, 10(48): 145-147.
    [3] West KL, Fernandez ML. Guinea pigs as models to study the hypocholesterolemic effects of drugs [J]. Cardiovasc Drug Rev, 2004, 22(1): 55-70.
    [4] 李金莲, 杨润梅, 高南南. 豚鼠:一种良好的高脂血症模型动物 [J]. 中国实验动物学报, 2009, 17(3): 239-242.
    [5] 施新猷. 现代医学实验动物学 [M]. 北京, 人民军医出版社, 2000: 100-101.
    [6] Aoki T, Yamazaki H, Suzuki T, et al. Cholesterol-lowering effect of NK-104, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, in guinea pig model of hyperlipidemia [J]. Arzneimittelforschung, 2001, 51(3): 197-203.
    [7] Xu CH, Fang DL, Chen X, et al. Effect of telmisartan on the therapeutic efficacy of pitavastatin in high-fat diet induced dyslipidemic guinea pigs [J]. Eur J Pharmacol, 2015, 6(5): 364-371.
    [8] 余林德, 陈占利. 中西医治疗高脂血症临床研究进展 [J]. 亚太传统医药, 2014,10(22): 35-38.
    [9] 杨晓光, 翟凤英, 朴建华. 中国居民营养现状调查 [J]. 中国预防医学杂志, 2010, 11(1): 5-7.
    [10] Conde K, Jimenez MV, Krause BR, et al. Hypocholesterolemic action of atorvastatin are associated with alterations on hepatic cholesterol metabolism and lipoprotein composition in the guinea pig [J]. J Lipid Res, 1996, 37: 2372-2382.
    [11] Kensaku M, Kenichi Y, Eisuke FS, et al. Enhanced oxidative stress in neutrophils from hyperlipidemic guinea pig [J]. Atherosclerosis, 2005, 181: 87-92.
    [12] Department of Health and Human Service. Scientific Report of the 2015 Dietary Guidelines Advisory Committee [R]. The United States: Dietary Guidelines Advisory Committee, 2015, 2.
    Related
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation
Share
Article Metrics
  • Abstract:2105
  • PDF: 1789
  • HTML: 0
  • Cited by: 0
History
  • Revised:August 14,2015
  • Online: September 30,2015
Article QR Code